Dr Reddys Laboratories (RDY) Return on Capital Employed [ROCE] (2009 - 2026)
Dr Reddys Laboratories' Return on Capital Employed [ROCE] was 17.75% in the quarter ended Jun 30, 2026, up 2.61 percentage points from 15.13% a year earlier but down 3.85 percentage points from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Return on Capital Employed [ROCE] at Dr Reddys Laboratories came in at 12.87%, down 10.20 percentage points from the prior year.
- Return on Capital Employed [ROCE] shows a five-year change of -2.11 percentage points (years ended Mar 2021 to Mar 2026).
- In earlier years, Return on Capital Employed [ROCE] was 23.07% in the year ended Mar 31, 2025 (-2.89 pp), 25.97% in the year ended Mar 31, 2024 (+1.53 pp), 24.44% in the year ended Mar 31, 2023 (+8.91 pp) and 15.52% in the year ended Mar 31, 2022 (+0.54 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between 11.56% (the quarter ended Sep 30, 2024) and 25.82% (the quarter ended Jun 30, 2023) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of -0.26 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was the quarter ended Jun 30, 2023 (a gain of 11.85 percentage points); the worst was the quarter ended Sep 30, 2024 (a drop of 13.90 percentage points).
- Per Business Quant data, RDY's Return on Capital Employed [ROCE] in the three quarters before the quarter ended Jun 30, 2026 was 21.60% (quarter ended Mar 31, 2026), 14.96% (quarter ended Dec 31, 2025) and 14.26% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | 17.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.75% |
| Mar 31, 2026 | 21.60% |
| Dec 31, 2025 | 14.96% |
| Sep 30, 2025 | 14.26% |
| Jun 30, 2025 | 15.13% |
| Mar 31, 2025 | 15.48% |
| Dec 31, 2024 | 15.98% |
| Sep 30, 2024 | 11.56% |
| Jun 30, 2024 | 12.30% |
| Mar 31, 2024 | 12.81% |
| Dec 31, 2023 | 20.09% |
| Sep 30, 2023 | 25.46% |
| Jun 30, 2023 | 25.82% |
| Mar 31, 2023 | 25.79% |
| Dec 31, 2022 | 19.76% |
| Sep 30, 2022 | 16.55% |
| Jun 30, 2022 | 13.97% |
| Mar 31, 2022 | 14.72% |
| Dec 31, 2021 | 16.96% |
| Sep 30, 2021 | 18.34% |
API Access
Dr Reddys Laboratories Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();